Stay updated with breaking news from Trinav Infusion System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reported revenues of $5.7 million in 4Q23, up 77% over prior year Full year revenues of $18.5 million, up 49% over prior year Gross Margin of 90% in 4Q23 and 86% for full year CMS...
Deerfield Management Company L.P. Series C acquired a new stake in shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the third quarter, HoldingsChannel reports. The institutional investor acquired 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC purchased a new position in TriSalus Life Sciences in […]
Deerfield Management Company L.P. Series C bought a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC acquired a new position in […]
Deerfield Management Company L.P. Series C bought a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC acquired a new position in […]
04.11.2023 - TriSalus Life Sciences Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today presented additional Phase 1 clinical data ... Seite 1